Knee · 5 min read
Stem cells vs knee replacement: who is a candidate?
How regenerative treatment and a knee replacement compare, and how your X-ray tells which one fits you today.
Short answer
Stem cell therapy and knee replacement serve different stages of knee osteoarthritis. Regenerative treatment, a one-day application, is best suited to mild to moderate osteoarthritis and aims to reduce pain and improve movement, helping some patients delay surgery. Replacement is major surgery for advanced, bone-on-bone wear. Your X-ray grade is what decides.
In 30 seconds
- Regenerative treatment is a one-day application with no hospital stay or surgical recovery.
- The best candidates have mild to moderate osteoarthritis (grades 2 and 3).
- A specialist reviews your X-ray or MRI to tell you which option fits your knee today.
How do the two options compare?
Both aim for the same thing: less pain and a knee you can use. They get there in very different ways. A replacement swaps the worn joint surfaces for an implant. Regenerative treatment with mesenchymal stem cells works on the inflammation that keeps the joint sore and stiff.
Who is a good candidate for stem cells?
Radiologists grade knee osteoarthritis from 1 to 4. In grades 2 and 3 the cartilage is thinner but still present, and inflammation causes a large part of the pain. That is where regenerative treatment has the most room to help. In grade 4, with bone touching bone, a replacement is usually the right answer.
Ask your doctor for your exact radiographic grade. If nobody has given you a number, a recent standing X-ray is enough for our specialist to tell you.
What does the evidence show?
Randomised trials and recent meta-analyses report improvements in pain and function after mesenchymal stem cell treatment in selected knee osteoarthritis patients, with a good safety profile. A trial with umbilical-cord cells also showed better results than hyaluronic acid. Results vary between people, which is why candidacy matters so much.
Why delaying a replacement can matter
Implants have a lifespan, and younger, active patients may face a second surgery later in life. For them, gaining comfortable years before a replacement can be valuable. For others, the priority is simply walking, sleeping and climbing stairs with less pain right now.
- Treatment in a single day at Hospital Puerta de Hierro Andares.
- Mesenchymal stem cells from Wharton’s jelly.
- Follow-up at 30, 90 and 180 days with your local doctor in copy.
Is this for you?
- Your X-ray or MRI shows mild to moderate knee osteoarthritis.
- You want to explore options before a replacement, or you have been told it is still early for one.
- Physical therapy or injections helped only for a while.
Frequently asked questions
Can stem cells replace a knee replacement?
They serve different stages. Regenerative treatment fits mild to moderate osteoarthritis; advanced, bone-on-bone wear usually needs a replacement.
How long is the recovery?
The application is done in one day and most patients fly home within 2–3 days. Your physician gives you an activity plan.
Can I have it if I was told I need a replacement?
Send your imaging. In some cases treatment helps delay that decision; the specialist tells you honestly what fits.
How much does it cost for the knee?
The reference range for the knee is USD 5,000 to 9,000, confirmed after a free review of your imaging.
Stemlife Clinic at a glance
- Location
- Guadalajara, Mexico · Hospital Puerta de Hierro Andares
- Cells
- Mesenchymal stem cells from Wharton’s jelly (umbilical cord)
- Treatment
- One application in a single day; plan 2–3 days in Guadalajara
- Price
- From USD 5,000, confirmed after a free medical assessment
Medically reviewed by Dr. Guillermo Quezada Navarro · November 2026
Sources
- AAOS OrthoInfo · Total knee replacement
- NIAMS (NIH) · Osteoarthritis
- Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2025.
- Umbilical cord-derived mesenchymal stromal cells for knee osteoarthritis: a controlled randomized phase I/II trial. Stem Cells Transl Med. 2019.
General educational information. Individual results vary and are not guaranteed.
